SonarMD
Latest round
- Series A
Last raised
- Dec 2018
Total raised
- $11M
Investors
- 2
About SonarMD
Founded in 2015 and headquartered in Elgin, US, SonarMD, LLC specializes in providing a digital platform for monitoring patients with inflammatory bowel disease. The company has undergone no significant pivots in its strategy. The founder, Lawrence Kosinski, has a background in healthcare technology, although details of previous ventures are not available.SonarMD offers a comprehensive digital platform designed to monitor and manage the health of patients with inflammatory bowel disease (IBD), focusing on conditions such as Crohn's disease and ulcerative colitis. The core service involves a monthly health assessment delivered through secure email or text, based on validated clinical surveys like the Crohn’s Disease Activity Index and Ulcerative Colitis Disease Activity Index. This assessment generates a personalized Sonar Score that reflects the patient’s health status without the patient directly viewing the score. SonarMD actively collaborates with healthcare providers and health plans to facilitate early intervention for patients experiencing symptoms of clinical decline, thereby improving patient outcomes and reducing healthcare costs.SonarMD's revenue model is structured around partnerships with healthcare providers and health plans, focusing on a value-based care approach. Through these partnerships, practices receive a share of savings achieved by utilizing SonarMD’s monitoring system, which includes a prepayment on shared savings distributed as a per member, per quarter fee. This financial structure allows providers to maintain their traditional fee-for-service reimbursement while benefiting from additional income generated through SonarMD's services. The firm’s engagement with practices is intended to enhance patient care management, leading to increased office visits and reduced emergency room visits.In the upcoming months, SonarMD plans to enhance its platform with new product offerings aimed at improving patient engagement and monitoring capabilities. The company is also targeting expansions into additional markets across the United States to reach a broader patient population.5 mn will support these initiatives, enabling SonarMD to reinforce its technological infrastructure and broaden its partnerships with healthcare organizations.
Who invested in SonarMD
2 investors across 1 round
See all investors in SonarMD
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 17, 2018
Amount
$11M
Investors
Questions about SonarMD
Who invested in SonarMD?
SonarMD has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SonarMD raised?
SonarMD has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SonarMD last raise money?
SonarMD's most recent round on record is a Series A, in Dec 2018.
What does SonarMD do?
Founded in 2015 and headquartered in Elgin, US, SonarMD, LLC specializes in providing a digital platform for monitoring patients with inflammatory bowel disease.
Where is SonarMD headquartered?
SonarMD is headquartered in Elgin, US.
Which VCs invest in companies like SonarMD?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at SonarMD's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like SonarMD? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.